ICON plc - Ordinary Shares · Transaction Mar 5, 2026 · Filed Apr 3, 2026 · $100,001 to $250,000
ICON PLC
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ICLR moving today?
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ICLR overview
Related filings and maps
Congress activity in ICLR
ICLR · Transaction Feb 12, 2026 · Filed Mar 12, 2026 · $1,001 to $15,000
ICLR · Transaction Sep 4, 2024 · Filed Sep 6, 2024 · $1,001 to $15,000
ICLR · Transaction Jun 12, 2024 · Filed Sep 2, 2024 · $1,001 to $15,000
ICON plc - Ordinary Shares · Transaction Jan 31, 2023 · Filed Feb 14, 2023 · $1,001 to $15,000
ICLR contract awards, year to date.
Public federal awards linked to this ticker.
ICLR lobbying filings, year to date.
Registered lobbying filings matched to ICON PLC.
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY (TSMC)
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY (TSMC)
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY (TSMC)